Christophe Echeverri: from Canada to Cenix

Samantha Barton (Interviewer), Jayne V. Carey (Interviewer)
{"title":"Christophe Echeverri: from Canada to Cenix","authors":"Samantha Barton (Interviewer),&nbsp;Jayne V. Carey (Interviewer)","doi":"10.1016/S1741-8372(04)02453-3","DOIUrl":null,"url":null,"abstract":"<div><p>Christophe Echeverri started his research career in the field of molecular cell biology at the University of Ottawa, Canada. After completing his Masters degree in Ottawa in 1992, Christophe moved to the University of Massachusetts, MA, USA, where he studied the role of microtubule-based motors for his PhD. In 1998, a transatlantic move took Christophe to the European Molecular Biology Laboratory in Heidelberg, Germany, where his career soon took a dramatic turn. His successful post-doctorate work in applying the RNA-interference (RNAi) technique at the genome scale in <em>Caenorhabditis elegans</em> led him to co-found his own company, Cenix BioScience, in 1999. The company provides RNAi-based research services for target discovery and validation projects, worldwide. In 2003, Christophe was voted as one of the world's 100 Top Young Innovators by <em>Technology Review</em>, the Massachusetts Institute of Technology's magazine of innovation.</p></div>","PeriodicalId":100382,"journal":{"name":"Drug Discovery Today: TARGETS","volume":"3 5","pages":"Pages 179-182"},"PeriodicalIF":0.0000,"publicationDate":"2004-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1741-8372(04)02453-3","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Discovery Today: TARGETS","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1741837204024533","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Christophe Echeverri started his research career in the field of molecular cell biology at the University of Ottawa, Canada. After completing his Masters degree in Ottawa in 1992, Christophe moved to the University of Massachusetts, MA, USA, where he studied the role of microtubule-based motors for his PhD. In 1998, a transatlantic move took Christophe to the European Molecular Biology Laboratory in Heidelberg, Germany, where his career soon took a dramatic turn. His successful post-doctorate work in applying the RNA-interference (RNAi) technique at the genome scale in Caenorhabditis elegans led him to co-found his own company, Cenix BioScience, in 1999. The company provides RNAi-based research services for target discovery and validation projects, worldwide. In 2003, Christophe was voted as one of the world's 100 Top Young Innovators by Technology Review, the Massachusetts Institute of Technology's magazine of innovation.

Christophe Echeverri:从加拿大到凤凰城
Christophe Echeverri在加拿大渥太华大学开始了他在分子细胞生物学领域的研究生涯。1992年在渥太华完成硕士学位后,Christophe搬到了美国马萨诸塞州马萨诸塞大学,在那里他研究了微管马达的作用,并获得了博士学位。1998年,一次跨大西洋的旅行把克里斯托夫带到了德国海德堡的欧洲分子生物学实验室,在那里他的职业生涯很快发生了戏剧性的转变。他的博士后工作是在秀丽隐杆线虫基因组规模上应用rna干扰(RNAi)技术,这使他在1999年与人合作创办了自己的公司Cenix BioScience。该公司为全球目标发现和验证项目提供基于rnai的研究服务。2003年,Christophe被麻省理工学院的创新杂志《技术评论》(Technology Review)评选为全球100位顶尖青年创新者之一。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信